See more : Österreichische Post AG (OSTIY) Income Statement Analysis – Financial Results
Complete financial analysis of St.Shine Optical Co.,Ltd. (1565.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of St.Shine Optical Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- JPMorgan Chase & Co. (JPM.NE) Income Statement Analysis – Financial Results
- European Sustainable Growth Acquisition Corp. (EUSG) Income Statement Analysis – Financial Results
- Japan Communications Inc. (9424.T) Income Statement Analysis – Financial Results
- Immuneering Corporation (IMRX) Income Statement Analysis – Financial Results
- Monitor Ventures Inc. (AVCVF) Income Statement Analysis – Financial Results
St.Shine Optical Co.,Ltd. (1565.TWO)
About St.Shine Optical Co.,Ltd.
St.Shine Optical Co.,Ltd. engages in the manufacture, trading, and sale of contact lenses, optical lenses, and related products in Asia, Europe, America, and Taiwan. The company's product portfolio includes daily disposable, frequent replacement, color, and silicone hydrogel soft contact lens, as well as cast-molded soft contact lenses. The company offers its products under the Ticon brand name. The company's products are used to correct vision defects, such as myopia, hyperopia, and astigmatism. The company was formerly known as First Optical Co., Ltd. and changed its name to St.Shine Optical Co.,Ltd. in 1986. St.Shine Optical Co.,Ltd. was founded in 1986 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.39B | 5.00B | 5.40B | 5.01B | 6.35B |
| Cost of Revenue | 3.42B | 3.53B | 3.79B | 3.63B | 4.25B |
| Gross Profit | 975.25M | 1.47B | 1.61B | 1.37B | 2.10B |
| Gross Profit Ratio | 22.20% | 29.47% | 29.83% | 27.42% | 33.04% |
| Research & Development | 69.91M | 48.83M | 53.74M | 43.83M | 72.00M |
| General & Administrative | 128.14M | 160.13M | 149.81M | 145.83M | 160.48M |
| Selling & Marketing | 176.46M | 196.90M | 197.43M | 177.84M | 232.97M |
| SG&A | 304.59M | 357.02M | 347.23M | 323.66M | 375.24M |
| Other Expenses | 0.00 | 209.60M | -69.34M | -52.04M | 0.00 |
| Operating Expenses | 374.50M | 405.85M | 400.98M | 367.49M | 447.24M |
| Cost & Expenses | 3.79B | 3.93B | 4.19B | 4.00B | 4.70B |
| Interest Income | 37.86M | 11.84M | 2.22M | 6.16M | 18.62M |
| Interest Expense | 10.23M | 9.79M | 10.52M | 13.48M | 15.85M |
| Depreciation & Amortization | 322.04M | 328.54M | 320.00M | 329.73M | 358.98M |
| EBITDA | 1.01B | 1.62B | 1.48B | 1.28B | 1.99B |
| EBITDA Ratio | 23.01% | 32.28% | 27.09% | 25.75% | 31.65% |
| Operating Income | 605.70M | 1.29B | 1.14B | 959.29M | 1.65B |
| Operating Income Ratio | 13.79% | 25.72% | 21.16% | 19.16% | 25.99% |
| Total Other Income/Expenses | 73.22M | -5.69M | 10.60M | -17.99M | -35.07M |
| Income Before Tax | 678.92M | 1.28B | 1.15B | 941.30M | 1.61B |
| Income Before Tax Ratio | 15.45% | 25.60% | 21.36% | 18.80% | 25.44% |
| Income Tax Expense | 132.96M | 262.04M | 205.90M | 196.19M | 327.51M |
| Net Income | 545.95M | 1.02B | 947.76M | 745.11M | 1.29B |
| Net Income Ratio | 12.43% | 20.37% | 17.55% | 14.88% | 20.28% |
| EPS | 10.83 | 20.21 | 18.80 | 14.78 | 25.53 |
| EPS Diluted | 10.74 | 20.05 | 18.67 | 14.68 | 25.37 |
| Weighted Avg Shares Out | 50.42M | 50.42M | 50.42M | 50.42M | 50.42M |
| Weighted Avg Shares Out (Dil) | 50.85M | 50.83M | 50.77M | 50.77M | 50.75M |
Source: https://incomestatements.info
Category: Stock Reports